Advertisement

International Journal of Hematology

, Volume 94, Issue 5, pp 423–428 | Cite as

The discovery of ATL: an odyssey in restrospect

  • Junji Yodoi
  • Michiyuki Maeda
Special Feature

Abstract

Forty years have passed since our initial description of peculiar cases of adult-onset leukemia with abnormal cells having multi-convoluted nuclei and T cell properties, frequent in the southern regions of Japan in the early 1970s. Retrospectively, the study of adult T cell leukemia (ATL) and the related virus HTLV-I was a forerunner for all of human retrovirology, in which AIDS and the related retrovirus HIV were identified a few years later in the 1980s. Using the anti-TAC monoclonal antibody generated by the late Takashi Uchiyama during his stay in T. A. Waldmann's laboratory in NIH Bethesda, a cDNA encoding IL-2Rα chain was cloned by our group in Kyoto and by Waldmann’s group in Bethesda. Abnormal IL-2Rα chain expression and the IL-2 dependency of ATL cell lines greatly contributed to the study of leukemogenesis of ATL. A new soluble factor named ADF/ATL-derived factor was also detected in ATL cell lines. After years of study, ADF proved to be a first human counterpart of thiol-related oxido-reductase thioredoxin/TRX, which opened the field of redox regulation of cell signaling involved in a variety of diseases. Close interaction among Drs. Kimishige Ishizaka, Kiyoshi Takastuki and T. A. Waldmanns before ATL and HTLV-I study was an essential base for our initiation of ATL research with Takashi Uchiyama and many other colleagues.

Keywords

ATL Adult T cell leukemia IL-2R ADF TRX HTLV AIDS 

References

  1. 1.
    Yodoi J, Takatsuki K, Masuda T. Two cases of T-cell chronic lymphocytic leukemia in Japan. N Engl J Med. 1974;290:572–3.PubMedGoogle Scholar
  2. 2.
    Yodoi J, Takatsuki K, Aoki N, Masuda T. Chronic lymphocytic leukemia of T-cell origin: demonstration in two cases by the use of anti-thymocyte membrane antiserum. Nippon Ketsueki Gakkai Zasshi. 1974;37(3):289–92.PubMedGoogle Scholar
  3. 3.
    Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481–92.PubMedGoogle Scholar
  4. 4.
    Kalyanaraman VS, Sarngadharan MG, Nakao Y, Ito Y, Aoki T, Gallo RC. Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan. Proc Natl Acad Sci USA. 1982;79:1653–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA. 1982;79:2031–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Uchiyama T, Broder S, Waldmann TA. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol. 1981;126:1393–7.PubMedGoogle Scholar
  7. 7.
    Leonard WJ, Depper JM, Crabtree GR, Rudikoff S, Pumphrey J, Robb RJ, Krönke M, Svetlik PB, Peffer NJ, Waldmann TA, et al. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature. 1984;311:626–31.PubMedCrossRefGoogle Scholar
  8. 8.
    Nikaido T, Shimizu A, Ishida N, Sabe H, Teshigawara K, Maeda M, Uchiyama T, Yodoi J, Honjo T. Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature. 1984;311:631–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Waldmann TA, Leonard WJ, Depper JM, Krönke M, Goldman CK, Oh T, Greene WC. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia. Princess Takamatsu Symp. 1984;15:259–68.PubMedGoogle Scholar
  10. 10.
    Yodoi J, Masuda T, Miyama M, Maeda M, Ichikawa Y. Interaction of lymphocytes and macrophage cell line cells (M1 cells). I. Functional maturation and appearance of Fc receptors in M1 cells. Cell Immunol. 1978;39:5–17.PubMedCrossRefGoogle Scholar
  11. 11.
    Teshigawara K, Maeda M, Nishino K, Nikaido T, Uchiyama T, Tsudo M, Wano Y, Yodoi J. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression. J Mol Cell Immunol. 1985;2:17–26.PubMedGoogle Scholar
  12. 12.
    Maeda M, Shimizu A, Ikuta K, Okamoto H, Kashihara M, Uchiyama T, Honjo T, Yodoi J. Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement. J Exp Med. 1985;162:2169–74.PubMedCrossRefGoogle Scholar
  13. 13.
    Nishinaka Y, Nishiyama A, Masutani H, Oka S, Ahsan KM, Nakayama Y, Ishii Y, Nakamura H, Maeda M, Yodoi J. Loss of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 in human T-cell leukemia virus type I-dependent T-cell transformation: implications for adult T-cell leukemia leukemogenesis. Cancer Res. 2004;64:1287–92.PubMedCrossRefGoogle Scholar
  14. 14.
    Chen Z, Lopez-Ramos DA, Yoshihara E, Maeda Y, Masutani H, Sugie K, Maeda M, Yodoi J. Thioredoxin-binding protein-2 (TBP-2/VDUP1/TXNIP) regulates T-cell sensitivity to glucocorticoid during HTLV-I-induced transformation. Leukemia. 2011;25:440–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H, Yodoi J. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J. 1989;8:757–64.PubMedGoogle Scholar
  16. 16.
    Wakasugi N, Tagaya Y, Wakasugi H, Mitsui A, Maeda M, Yodoi J, Tursz T. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein–Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci USA. 1990;87(21):8282–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Ikuta K, Takami M, Kim CW, Honjo T, Miyoshi T, Tagaya Y, Kawabe T, Yodoi J. Human lymphocyte Fc receptor for IgE: sequence homology of its cloned cDNA with animal lectins. Proc Natl Acad Sci USA. 1987;84:819–23.PubMedCrossRefGoogle Scholar
  18. 18.
    Kondo N, Ishii Y, Son A, Sakakura-Nishiyama J, Kwon YW, Tanito M, Nishinaka Y, Matsuo Y, Nakayama T, Taniguchi M, Yodoi J. Cysteine-dependent immune regulation by TRX and MIF/GIF family proteins. Immunol Lett. 2004;92:143–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Son A, Kato N, Horibe T, Matsuo Y, Mochizuki M, Mitsui A, Kawakami K, Nakamura H, Yodoi J. Direct association of thioredoxin-1 (TRX) with macrophage migration inhibitory factor (MIF): regulatory role of TRX on MIF internalization and signaling. Antioxid Redox Signal. 2009;11:2595–605.PubMedCrossRefGoogle Scholar
  20. 20.
    Yoshihara E, Chen Z, Matsuo Y, Masutani H, Yodoi J. Thiol redox transitions by thioredoxin and thioredoxin-binding protein-2 in cell signaling. Methods Enzymol. 2010;474:67–82.PubMedCrossRefGoogle Scholar
  21. 21.
    Ogawa M, McIntyre OR, Ishizaka K, Ishizaka T, Terry WD, Waldmann TA. Biologic properties of E myeloma proteins. Am J Med. 1971;51:193–9.PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2011

Authors and Affiliations

  1. 1.Department of Biological Responses, Institute for Virus ResearchKyoto UniversityKyotoJapan
  2. 2.Center for Cell Signaling Research/CCSR and Bio-Redox System Research CenterEhwa Womans UniversitySeoulKorea

Personalised recommendations